AstraZeneca’s diabetes drug Farxiga could face generic competition in the US, after the FDA gave tentative approval to a generic rival from India’s Glenmark, although it is unclear when the
Experts from NASA are keeping a close eye on UK research that tests whether drugs commonly used in diabetes work against raised brain pressure – a painful problem sometimes seen in women wi
The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise.